4147.TWO - TaiMed Biologics Inc.

Taipei Exchange - Taipei Exchange Delayed Price. Currency in TWD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Total Revenue
610,599
241,041
8,436
2,076
0
Cost of Revenue
490,904
260,898
-
0
0
Gross Profit
119,695
-19,857
-
2,076
0
Operating Expenses
Research Development
588,580
440,390
510,737
276,609
442,462
Selling General and Administrative
40,973
42,628
42,915
38,365
48,680
Total Operating Expenses
629,553
300,928
553,652
314,974
471,680
Operating Income or Loss
-509,858
-320,785
-545,216
-312,898
-471,680
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-
-
-
-
-
Income Before Tax
-650,099
-321,710
-524,554
-281,962
-471,680
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-650,099
-321,710
-524,554
-281,962
-471,680
Net Income
-650,099
-321,710
-524,554
-281,962
-471,680
Net Income available to common shareholders
-650,099
-321,710
-524,554
-281,962
-471,680
Reported EPS
Basic
-
-1.28
-2.10
-1.14
-2.16
Diluted
-
-1.28
-2.10
-1.14
-2.16
Weighted average shares outstanding
Basic
-
250,738
250,221
248,369
218,043
Diluted
-
250,738
250,221
248,369
218,043
EBITDA
-
-257,876
-541,430
-309,411
-468,248